Regeneron Pharmaceuticals has announced plans to acquire the genetic testing company 23andMe for $256 million, with a clear ...

Regeneron (REGN) announced initial results from two cohorts of the Phase 1b LINKER-MM2 trial evaluating linvoseltamab in combination with two different proteasome inhibitors – carfilzomib or ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Some public libraries have yearbooks from the schools that used to serve their towns. The Hoyt Memorial Library in Kingston ...